Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: Benefits Of Sodium Glucose Co-transporter-1/2 Inhibition With Sotagliflozin Across The Full Spectrum Of Ejection Fraction, Including Heart Failure With Preserved Ejection Fraction
Disclosures: TBD
Clinical Trial Results
Disclosures: TBD